Abstract
Background: Silver nanofabricated products are well known elements from ages, and have great demand at present due to their massive significance in therapeutics, diagnostics, theranostics and targeted drug delivery systems. Silver nanoparticles (AgNPs) came into limelight, owing to their diverse pharmacotherapeutic potentials such as antiproliferative, anti-infective, anti-inflammatory, anti-coagulant etc. This resulted in increased commercial production of AgNPs and Ag-related products at highest pace. In majority of commercial AgNP production, traditionally wet chemical reduction techniques are employed that utilize chemicals that are non-ecofriendly, produce by-products, emit harmful substances and are expensive. Plant extracts are most environment friendly, easily available and are economically viable. The biological mediated approach serves as the most promising alternative to synthesize size-controlled AgNPs commercially. Keywords: Extract, green synthesis, nanomedicine, nanoparticles, patents, silver.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
